Pôle pharmacie, CHU de Besançon, 3, boulevard Alexandre-Fleming, 25030 Besançon cedex, France; UMR Inserm1098, interactions hôte-greffon-tumeur - ingénierie cellulaire et génique, université Bourgogne-Franche-Comté, Besançon, France.
Pôle pharmacie, CHU de Besançon, 3, boulevard Alexandre-Fleming, 25030 Besançon cedex, France.
Infect Dis Now. 2021 May;51(3):285-289. doi: 10.1016/j.medmal.2020.10.012. Epub 2020 Oct 16.
Influenza vaccination coverage currently remains below the 75% recommended threshold by the World Health Organization. To correct this situation, experiments have been successively carried out in France to enable community pharmacists to vaccinate at-risk populations. In this context, a study was conducted with pharmacists from the French Franche-Comté region to evaluate their positioning, needs and expectations regarding influenza vaccination at community pharmacies.
A survey was created and sent to licensed pharmacists in March of 2018. This consisted of 4 parts: characteristics of the community pharmacy; positioning of the pharmacist regarding vaccinations carried out at the pharmacy; training needs and expectations; and willingness to implement vaccinations.
The participation rate in this survey was 32% (137/427). More than 90% of the pharmacists agreed that community pharmacies' assets were adequate for the implementation of these vaccinations (accessibility and availability), although 52% considered this complicated. Their main fears were reluctance from patients and conflicts of interest with other health professionals authorized to vaccinate (58%). The needs and expectations regarding pharmacy student training were essential for 94% of them as well as continuous training of practicing pharmacists (96%). The willingness of pharmacists to vaccinate stemmed from the fact that influenza vaccination coverage would increase for at-risk subjects (36%).
This survey allowed us to assess the favorable positioning and the real interest of pharmacists from Franche-Comté regarding the influenza vaccination done at community pharmacies, given the proviso that they were given relevant training and allocated adequate resources.
目前，流感疫苗接种率仍低于世界卫生组织建议的 75%。为了纠正这种情况，法国已相继开展实验，使社区药剂师能够为高危人群接种疫苗。在此背景下，对法国弗朗什-孔泰地区的药剂师进行了一项研究，以评估他们在社区药房接种流感疫苗的定位、需求和期望。
2018 年 3 月，我们创建并向持照药剂师发送了一份调查问卷。问卷分为 4 部分：社区药房的特点；药剂师在药房进行疫苗接种的定位；培训需求和期望；以及实施疫苗接种的意愿。
该调查的参与率为 32%（137/427）。超过 90%的药剂师认为社区药房的资产足以实施这些疫苗接种（可及性和可用性），尽管 52%的人认为这很复杂。他们主要担心的是患者不愿意和与其他有权接种疫苗的卫生专业人员发生利益冲突（58%）。94%的人认为对药学专业学生进行培训以及对在职药剂师进行持续培训的需求和期望至关重要。药剂师愿意接种疫苗的原因是，高危人群的流感疫苗接种覆盖率将会提高（36%）。
这项调查使我们能够评估弗朗什-孔泰地区药剂师对社区药房接种流感疫苗的有利定位和真正兴趣，前提是他们接受了相关培训并分配了足够的资源。
